Semaglutide is part of a group of medicines called GLP-1 receptor agonists, commonly used to manage type 2 diabetes. In recent years, it has also gained worldwide attention for helping with weight ...
To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...
Hosted on MSN
50+ branded semaglutide generics to enter India as diabetes drug patent expires in March 2026
The upcoming expiry of the semaglutide patent in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the ...
— Yale Law slipped to No. 2 on U.S. News & World Report’s latest law school rankings, ending a 36-year reign on the top. — Big legal AI startups are offering free tools to top law schools as they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results